WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network
12.11.2026 19:00:00 EET | Business Wire | Press release
WHOOP, the human performance brand, today launched WHOOP Humans, a new feature that lets members follow friends and family, share fitness, health, and performance data they choose, and support each other's progress.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112176779/en/
WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network
For more than a decade, WHOOP has helped members better understand their own health and performance. Now, WHOOP Humans extends that experience beyond the individual, making it easier to celebrate achievements, encourage progress, and look out for the people who matter most.
"In a world that's becoming increasingly artificial, we're building something deeply human,” said Will Ahmed, Founder and CEO of WHOOP. “This is the most verifiably human network ever launched. Every account represents a real person with a verified heartbeat. They have real goals, challenges, and achievements. That's what makes WHOOP Humans different, and it’s a big area of investment for us."
THE MOST VERIFIABLY HUMAN NETWORK EVER
As legacy social media platforms become increasingly saturated with artificial intelligence, automated accounts and bots, and manufactured content, WHOOP Humans offers a fundamentally different approach to connection: a network that is entirely human.
While traditional social networks are increasingly filled with artificial content, WHOOP Humans connects people through something real: their health, performance, and everyday experiences. Members can share WHOOP data, including Sleep, Recovery, Strain, activities, and achievements, choosing what they want others to see, creating opportunities for authentic connection rooted in real experiences rather than curated online personas. In all cases, the underlying physiological data comes from a wearable device, creating a foundation of real-world information that cannot simply be generated as a conventional text post. This makes WHOOP Humans a distinctly human-centered network, designed to prioritize genuine progress and connection.
For WHOOP member Mika Bublitz, WHOOP Humans is about more than following friends' progress. It's about knowing when someone might need a little extra support.
"Sometimes people don't tell you when they're not feeling their best. If I see a friend's Recovery is low, I can check in and say, 'Hey, it's okay to take it easy today.' That's what I like about WHOOP Humans. It gives us another way to look out for each other."
WHOOP members have already demonstrated the value of connection. Today, 57% of members belong to at least one WHOOP Team. While Teams bring members together through groups and leaderboards, WHOOP Humans makes those connections personal. Members can follow friends and family directly, explore the performance insights others choose to share, and offer encouragement through reactions and comments.
WHOOP Humans also introduces Moments, allowing members to share photos from workouts, personal milestones, and meaningful experiences. By bringing the stories behind the data into the WHOOP experience, Moments helps members celebrate not just the numbers, but the lives and achievements they represent. Members can also choose to keep Moments private.
PRIVACY AT THE CORE
WHOOP Humans is designed to make meaningful connections possible without compromising personal privacy. Members control what health and performance information they share, who can see it, and when they want to remain private.
Key privacy protections include:
- Granular health data controls: Members choose which metrics to share, including Recovery, Strain, Sleep, HRV, and resting heart rate.
- Control over connections: Members can manage their followers and remove individuals from their WHOOP Humans network.
- Stealth Mode: Members can temporarily hide their shared health and performance information without changing their sharing preferences.
- Sensitive activity protections: Activities designated as sensitive are not shared by default.
- Selective activity and achievement sharing: Members choose which workout types and achievements appear in WHOOP Humans.
- Private Moments: Members can keep personal photos and Moments private rather than sharing them with their network.
- Ongoing privacy management: Members can update their sharing preferences at any time.
These protections reflect a longstanding commitment to putting members in control of their personal health information. WHOOP does not sell or monetize a member’s personal health data.
WHOOP Humans is designed to demonstrate that greater connection and stronger privacy can coexist. Members can benefit from the encouragement, accountability, and support of the people around them without surrendering control over their most personal information.
With more than three million members worldwide, WHOOP has evolved from a product trusted by the world's best athletes into a platform helping people take greater control of how they feel, perform, and age. Members already open WHOOP more than eight times per day, reflecting the central role the product plays in their daily lives. WHOOP Humans represents the next chapter in that evolution.
WHOOP Humans is available to members in the WHOOP app beginning November 12, 2026. Existing WHOOP Teams will remain available. For more information, visit whoop.com or access the official press kit.
About WHOOP
WHOOP delivers a wearable membership to help people live healthier, longer lives and unlock extraordinary potential. Through a powerful 24/7 wearable with a 14-day battery life, WHOOP provides intelligent health guidance across sleep, recovery, strain, fitness, and longevity. The health platform includes an FDA-cleared ECG, a Healthspan longevity feature, Blood Pressure Insights, and Advanced Labs blood biomarker analysis. Research shows that people who wear WHOOP daily log more than 90 additional minutes of exercise per week, get over two extra hours of sleep, and have 10% higher heart rate variability.
Trusted by millions of members worldwide including athletes, global leaders, military operators, executives, and artists, WHOOP has become a modern symbol of disciplined, intentional living. WHOOP was founded in 2012 and is headquartered in Boston. The company has raised more than $900 million in venture capital, ships to 61 countries, and operates in six languages. To learn more or start a one-month free trial, visit whoop.com and connect with WHOOP on Instagram, X, Facebook, LinkedIn, and YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261112176779/en/
Contacts
Media Contact
Jack Taylor Worldwide
whoop@jacktaylorpr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application12.11.2026 19:09:00 EET | Press release
VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced that it has partnered with Clene Nanomedicine to cut the time to deliver biostatistical outputs for a pivotal ALS drug application submission by 80%. Veristat reduced the time from study data to validated tables, listings and figures (TLFs) from up to six weeks to just one week. Clene, a late-stage biotech company, leveraged Veristat’s recently launched InStat™ platform, the industry’s first zero-code, fully automated solution to accelerate clinical trial processes. Biostatistical TLFs sit on the critical path for submissions, yet most sponsors rely on antiquated processes that involve slow, manual workflows to produce them, making post-database lock one of the biggest bottlenecks to regulatory approval. To remove this barrier, Veristat uses its AI-enhanced platform to compress the timeline to submission-ready TLFs from weeks to days, with every output validated by stati
Integrated Hubs for Green Chemistry Research Aim to Transform How Chemicals and Materials Are Designed12.11.2026 18:00:00 EET | Press release
The Gordon and Betty Moore Foundation today announced four Integrated Research Hubs to explore new frontiers in chemical design, from materials that respond to their surroundings to molecules designed for safety from the start. Bringing together global researchers across institutions and disciplines, the hubs will investigate fundamental principles that could enable new capabilities in chemicals and materials while improving performance and protecting human health and the environment. The research priorities emerged through extensive engagement with the scientific community to identify the questions that could transform what chemistry can achieve. Each hub will connect researchers across institutions around one of four green chemistry focus areas: Safer molecular design: Led by The George Washington University, this hub will combine artificial intelligence and quantum chemistry to embed safety into chemical design from the outset. Adaptive catalytic systems: Led by the Max Planck Insti
Roquette Highlights Scalable Excipient and Capsule Solutions for Regional and Global Pharmaceutical Markets at CPHI India 202612.11.2026 17:00:00 EET | Press release
Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical excipients, will showcase its comprehensive portfolio of excipient and capsule solutions at CPHI India 2026, Hall 1, Booth 1I12 from November 23 to 25, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112803410/en/ Meet Roquette at CPHI India 2026, Hall 1, Booth 1I12 At the event, Roquette will demonstrate how it helps pharmaceutical manufacturers accelerate the journey from formulation to market with confidence. By combining technical expertise, trusted quality, meaningful innovation and close collaboration, Roquette helps customers address formulation, scale-up and manufacturing challenges across a broad range of pharmaceutical applications. As India continues to play a critical role in supplying medicines to patients around the world, pharmaceutical manufacturers face increasing demands for quality, regulatory compliance,
Tigo Energy and Google Cloud Pair AI-Powered Tools for Solar Installers and Utilities12.11.2026 16:00:00 EET | Press release
Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy software solutions, today announced a collaboration with Google Cloud to develop AI-enabled operational workflows for solar installers and distributed energy portfolios. By making core Tigo data and software products available through Google Cloud, Tigo aims to deliver faster deployment, simplified data integration, and additional insights with Gemini. The resulting workflows will help installers, asset managers, and energy operators more easily identify issues, prioritize actions, and automate routine operational tasks across growing fleets of distributed energy systems. As solar and storage portfolios expand, energy businesses are increasingly responsible for managing more sites, more system data, and more customer interactions without a proportional increase in operational resources. Through collaboration with Google Cloud, Tigo is developing AI-assisted workflows to help opera
Patsnap Releases State of Pharma Intelligence 2026 Report, Reveals Pharma's Cautious Embrace of AI in Decision-Making12.11.2026 16:00:00 EET | Press release
Patsnap, the AI-native innovation intelligence company for IP and R&D teams, today released "State of Pharma Intelligence 2026: The Confidence to Act", a benchmark report on how pharma teams use and trust AI in R&D, competitive intelligence and business development decisions. The report draws on responses from 130 senior leaders at Director level or above across the United States, the United Kingdom, Germany, Switzerland, and France, spanning drug developers, CDMOs/CMOs, CROs, and consulting and professional services firms. The survey was fielded in August 2026 in partnership with NewtonX. Patsnap commissioned the research to understand how AI is influencing decisions across pharma R&D and business development, what builds confidence in its output, and where intelligence workflows fall short. A central finding of the survey is that speed is limited less by finding the signal, than by trusting it. Among pharma teams using AI, internal alignment (48%) and validation time (26%) are the le
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom